The European Union’s drug regulator has indicated that a change to the product information for COVID-19 vaccines from AstraZeneca and Johnson & Johnson has been recommended to include a warning of a rare spinal cord condition called transverse myelitis.
TM is a rare condition that involves inflammation of one or both
sides of the spinal cord. Symptoms can include weakness in the limbs,
and tingling, numbness, pain or loss of pain sensation, or issues with
bladder and bowel function............To Read More...
No comments:
Post a Comment